which is better between semaglutide and tirzepatide We know about the growing popularity of for their positive weight loss outcomes. But how do these two treatments differ? Swipe to discover the key differences! Want to find A lot of our patients

Employer concerns about GLP-1 drugs for obesity The short- and long-term cost of GLP-1 drugs remains a concern for employers, as do questions regarding the long-term effectiveness of these drugs for weight loss, said Julie Stich (pictured above right), IFEBPs vice president of content

Con: No GLP-1 friendly standard When it comes to label claims, the lack of standardization of GLP-1 friendly is the ultimate con for brands looking to enter this space

Patients who tracked intake and confirmed deficits of 300+ calories daily lost an average of 1.1% body fat per month

Infused with potent ingredients meticulously selected for their brightening properties

The parasympathetic system is your brake

Results vary significantly from person to person based on their baseline levels and lifestyle